Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis

Molecular Biology of the Cell

Volumn 24, Issue 23, 2013, Pages 3754-3763

  Yoon, Mee Sup ^a   Chen, Jie ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FOLLISTATIN; GUANOSINE TRIPHOSPHATASE; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MYOD PROTEIN; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D1; PROTEIN KINASE B; PROTEIN RAG; PROTEIN RAGA; PROTEIN RAGB; PROTEIN RAGC; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GROWTH REGULATION; HOMEOSTASIS; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

AMINO ACIDS; ANIMALS; CELL DIFFERENTIATION; CLASS III PHOSPHATIDYLINOSITOL 3-KINASES; ENHANCER ELEMENTS, GENETIC; ENZYME ACTIVATION; FOLLISTATIN; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR II; MICE; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; ORGAN SPECIFICITY; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TOR SERINE-THREONINE KINASES;

EID: 84889024832     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-06-0353     Document Type: Article

References (52)

1. Agard DA, Hiraoka Y, Shaw P, Sedat JW (1989). Fluorescence microscopy in three dimensions. Methods Cell Biol 30, 353-377.
2. Andres V, Walsh K (1996). Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132, 657-666.
3. Bar-Peled L, Chantranupong L, Cherniack AD, Chen WW, Ottina KA, Grabiner BC, Spear ED, Carter SL, Meyerson M, Sabatini DM (2013). A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100-1106.
4. Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM (2012). Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 150, 1196-1208.
5. Barton-Davis ER, Shoturma DI, Sweeney HL (1999). Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167, 301-305.
6. Berkes CA, Tapscott SJ (2005). MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 16, 585-595.
7. Bodine SC et al. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3, 1014-1019.
8. Byfield MP, Murray JT, Backer JM (2005). hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 280, 33076-33082.
9. Ciavarra G, Zacksenhaus E (2010). Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift. J Cell Biol 191, 291-301.
10. Erbay E, Chen J (2001). The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem 276, 36079-36082.
11. Erbay E, Kim JE, Chen J (2005). Amino acid-sensing mTOR signaling. In: Nutrient and Cell Signaling, ed. J Zempleni and K Dakshinamurti, Boca Raton, FL: CRC Press, 353-380.
12. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J (2003). IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol 163, 931-936.
13. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J (2001). Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942-1945.
14. Florini JR, Ewton DZ, Magri KA (1991a). Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol 53, 201-216.
15. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS (1991b). "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266, 15917-15923.
16. Fox HL, Pham PT, Kimball SR, Jefferson LS, Lynch CJ (1998). Amino acid effects on translational repressor 4E-BP1 are mediated primarily by L-leucine in isolated adipocytes. Am J Physiol 275, C1232-C1238.
17. Ge Y, Chen J (2012). Mammalian target of rapamycin (mTOR) signaling network in skeletal myogenesis. J Biol Chem 287, 43928-43935.
18. Ge Y, Sun Y, Chen J (2011a). IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol 192, 69-81.
19. Ge Y, Wu AL, Warnes C, Liu J, Zhang C, Kawasome H, Terada N, Boppart MD, Schoenherr CJ, Chen J (2009). mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. Am J Physiol Cell Physiol 297, C1434-C1444.
20. Ge Y, Yoon MS, Chen J (2011b). Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1). J Biol Chem 286, 35675-35682.
21. Hamilton DL, Philp A, MacKenzie MG, Baar K (2010). Prolonged activation of S6K1 does not suppress IRS or PI-3 kinase signaling during muscle cell differentiation. BMC Cell Biol 11, 37.
22. Herningtyas EH, Okimura Y, Handayaningsih AE, Yamamoto D, Maki T, Iida K, Takahashi Y, Kaji H, Chihara K (2008). Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line. Biochim Biophys Acta 1780, 1115-1120.
23. Iovino S, Oriente F, Botta G, Cabaro S, Iovane V, Paciello O, Viggiano D, Perruolo G, Formisano P, Beguinot F (2012). PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation. Cell Death Differ 19, 1127-1138.
24. Jaber N, Dou Z, Lin RZ, Zhang J, Zong WX (2012). Mammalian PIK3C3/VPS34: the key to autophagic processing in liver and heart. Autophagy 8, 707-708.
25. Kimball SR ((2007). The role of nutrition in stimulating muscle protein accretion at the molecular level. Biochem Soc Trans 35, 1298-1301.
26. Laplante M, Sabatini DM (2012). mTOR signaling in growth control and disease. Cell 149, 274-293.
27. Louard RJ, Barrett EJ, Gelfand RA (1995). Overnight branched-chain amino acid infusion causes sustained suppression of muscle proteolysis. Metabolism 44, 424-429.
28. Ma XM, Blenis J (2009). Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10, 307-318.
29. MacKenzie MG, Hamilton DL, Murray JT, Taylor PM, Baar K (2009). mVps34 is activated following high-resistance contractions. J Physiol 587, 253-260.
30. McCarthy JJ, Esser KA (2010). Anabolic and catabolic pathways regulating skeletal muscle mass. Curr Opin Clin Nutr Metab Care 13, 230-235.
31. Nair KS, Schwartz RG, Welle S (1992). Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. Am J Physiol 263, E928-E934.
32. Naya FJ, Olson E (1999). MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 11, 683-688.
33. Nobukuni T (2005). Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102, 14238-14243.
34. Patti ME, Brambilla E, Luzi L, Landaker EJ, Kahn CR (1998). Bidirectional modulation of insulin action by amino acids. J Clin Invest 101, 1519-1529.
35. Perry RLS, Rudnicki MA (2000). Molecular mechanisms regulating myogenic determination and differentiation. Frontiers Biosci 5, d750-767.
36. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ (2001). Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3, 1009-1013.
37. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM (2010). Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290-303.
38. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501.
39. Sarbassov DD, Ali SM, Sabatini DM (2005). Growing roles for the mTOR pathway. Curr Opin Cell Biol 17, 596-603.
40. Shah OJ, Hunter T (2006). Turnover of the active fraction of IRS1 involves raptor-mTOR-and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis. Mol Cell Biol 26, 6425-6434.
41. Simonsen A, Tooze SA (2009). Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186, 773-782.
42. Sun Y, Chen J (2008). mTOR signaling: PLD takes center stage. Cell Cycle 7, 3118-3123.
43. Sun Y, Fang Y, Yoon MS, Zhang C, Roccio M, Zwartkruis FJ, Armstrong M, Brown HA, Chen J (2008). Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci USA 105, 8286-8291.
44. Sun Y, Ge Y, Drnevich J, Zhao Y, Band M, Chen J (2010). Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J Cell Biol 189, 1157-1169.
45. Tollefsen SE, Sadow JL, Rotwein P (1989). Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc Natl Acad Sci USA 86, 1543-1547.
46. Veverka V, Crabbe T, Bird I, Lennie G, Muskett FW, Taylor RJ, Carr MD (2008). Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene 27, 585-595.
47. Wiczer BM, Thomas G (2012). Phospholipase D and mTORC1: nutrients are what bring them together. Sci Signal 5, pe13.
48. Xu G, Kwon G, Marshall CA, Lin TA, Lawrence JC Jr, McDaniel ML (1998). Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem 273, 28178-28184.
49. Xu L, Salloum D, Medlin PS, Saqcena M, Yellen P, Perrella B, Foster DA (2011). Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). J Biol Chem 286, 25477-25486.
50. Yoon MS, Chen J (2008). PLD regulates myoblast differentiation through the mTOR-IGF2 pathway. J Cell Sci 121, 282-289.
51. Yoon MS, Du G, Backer JM, Frohman MA, Chen J (2011a). Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J Cell Biol 195, 435-447.
52. Yoon MS, Sun Y, Arauz E, Jiang Y, Chen J (2011b). Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. J Biol Chem 286, 29568-29574.